Clinical Trial Update: Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of Rituximab for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myalgic Encephalomyelitis Chronic Fatigue Syndrome

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: National Center of Neurology and Psychiatry, Japan | Conditions: Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | Phase 2 | Status: RECRUITING